"We wanted a system that was functionally very rich. Infor M3 was an obvious choice as it delivered functionality and facilitated compliance," says Miri Peleg, Dexcel Pharma director of information systems.
Israeli pharmaceutical manufacturer Dexcel Pharma has implemented Infor M3 globally. Delivered on time and on budget by Infor partner Intentia Israel, the enterprise resource planning (ERP) application will help Dexcel Pharma improve visibility and decision making, and achieve more uniformity across group companies in the UK, Germany, and Israel.
Infor M3 will help deliver consistency and facilitate transparency across the information generated by Dexcel's sales and distribution operations in Europe and the corporate headquarters in Israel, while supporting Dexcel's adherence to high standards of compliance required in the pharmaceutical industry.
"As a global pharmaceutical leader, we take the meticulous compliance demands of such a project very seriously," Peleg said.
Key to the success of the project was the smooth integration of sales, purchasing, production, distribution, and finance processes, specifically Infor M3's ability to support German-specific SEPA requirements. An automated warehouse and inventory module terminals have also been integrated.
"Global pharmaceutical manufacturing is complex and fast moving," said Alain Raflé, Infor regional channel manager for Israel. "The systems that underpin success must support regulatory compliance, and deliver operational agility and speed. Infor M3 is designed to do exactly that."